M. Jenusaitis Matthew's Insider Trades & SAST Disclosures

M. Jenusaitis Matthew's most recent trade in enVVeno Medical Corporation was a trade of 9,620 Common Stock done at an average price of $2.5 . Disclosure was reported to the exchange on Dec. 19, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
enVVeno Medical Corporation
Matthew Jenusaitis M. Director Purchase of securities on an exchange or from another person at price $ 2.53 per share. 19 Dec 2024 9,620 16,545 (0%) 0% 2.5 24,339 Common Stock
enVVeno Medical Corporation
M. Jenusaitis Matthew Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2024 19,752 19,752 - - Stock Options
enVVeno Medical Corporation
Matthew Jenusaitis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Dec 2023 13,856 13,856 - - Stock Options
enVVeno Medical Corporation
Matthew Jenusaitis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Nov 2022 8,403 8,403 - - Stock Options
enVVeno Medical Corporation
Matthew Jenusaitis Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Sep 2022 1,041 6,925 (0%) 0% - Common Stock
enVVeno Medical Corporation
Matthew Jenusaitis Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Sep 2022 1,041 0 - - Restricted Stock Units
enVVeno Medical Corporation
Matthew Jenusaitis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Nov 2021 7,211 7,211 - - Stock Options
enVVeno Medical Corporation
Matthew Jenusaitis Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Sep 2021 1,042 2,084 - - Restricted Stock Units
enVVeno Medical Corporation
Matthew Jenusaitis Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Sep 2021 1,042 5,884 (0%) 0% - Common Stock
enVVeno Medical Corporation
Matthew Jenusaitis Director Purchase of securities on an exchange or from another person at price $ 7.70 per share. 25 Aug 2021 1,300 4,842 (0%) 0% 7.7 10,010 Common Stock, $$0.00001 par value
enVVeno Medical Corporation
Matthew Jenusaitis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2021 5,673 5,673 - - Stock Option
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades